The Drug Science Podcast1 Sep 2021

44. Ibogaine with Professor Deborah Mash

This week on the Drug Science podcast, Professor Deborah Mash tells us about Ibogaine. A hallucinogenic compound derived from the roots of a West African shrub, sometimes used as a treatment for heroin or cocaine addiction.

Professor Mash found herself trying to reverse the damage that cocaine had caused on the streets of Miami, Florida. To explore new and novel therapies, she took a flight to Amsterdam to examine whether a West African shrub could be cure to cocaine and heroin dependency. Since that fateful trip, she’s been at the forefront of Ibogaine and Noribogaine research in the US. Now, she’s bringing that research to the UK for a landmark Ibogaine study in Manchester, England. Could Ibogaine be one of the most clinically significant advances in addiction medicine of the 21st century?

Deborah Mash is one of the world's foremost experts on the hallucinogenic drug ibogaine. She is the CEO and Founder of DemeRx Inc., a clinical-stage drug development company advancing ibogaine and its active metabolite noribogaine for the treatment of opioid use disorder. DemeRx has partnered with ATAI Life Sciences -- a global biotech platform with a special focus on psychedelic medicine -- to develop ibogaine for those suffering from opioid use disorder. Building on the extensive human data available around ibogaine, DemeRx and ATAI will submit Clinical Trial Applications for a Phase II study in opioid-dependent patients. This joint venture will also develop screening procedures, dosing guidelines, and best practices for opioid withdrawal management to ensure patient safety.

Enrol to the MAC Ibogaine Clinical trial

DemeRx

Miami’s drug war

Brain Endowment Bank

National Institute on Drug Abuse (NIDA)

U.S. Food and Drug Administration (FDA)

Psilocybin

MAC Manchester

Alexander Shulgin

Allopregnanolone (Brexanolone)

★ Support this podcast ★

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(159)

156. Training Grandmothers to Treat Depression with Dr Dixon Chibanda

In this episode, we speak with Dr Dixon Chibanda, a psychiatrist and professor at the London School of Hygiene and Tropical Medicine. He shares how losing a patient to suicide drove him towards commun...

5 Aug 41min

155. The History of Schizophrenia with Justin Garson

In this episode of the Drug Science Podcast, Dr Hannah Thurgur speaks with Dr Justin Garson, professor of philosophy at CUNY and the author of The Madness Pill, a history of Professor Solomon Snyder a...

22 Juli 47min

154. Is Medical Cannabis Over-Prescribed? with Dr Andy Barker

Join us in this episode as Prof Nutt speaks with Dr Andy Barker, a senior psychiatrist, medical cannabis prescriber, and the co-founder of This Native Mind. Andy shares his journey into medical cannab...

8 Juli 52min

153. Psychedelics, Couples and Sex with Sarah Tilley

In this episode, we speak with Sarah Tilley, a couple’s therapy pioneer and the CEO and founder of Beautiful Space, a provider of psilocybin programmes for couples. She details how her own divorce led...

24 Juni 42min

152. Cocaine and Alcohol with David Hillier

In this episode of the Drug Science Podcast, Prof Nutt speaks with David Hillier, a journalist and the creator of the Substack WHAT ARE YOU ON. David Hillier has been writing about drug culture and m...

10 Juni 38min

151. Francis Crick: From DNA to the Brain with Prof Matthew Cobb

In this episode, we speak to Prof Matthew Cobb, professor of zoology at the University of Manchester and author of Crick: A Mind in Motion, which profiles Francis Crick. Matthew shares insights into h...

27 Maj 57min

150. Synthetic Alcohol with David Orren

Join us in this episode of the Drug Science Podcast as Prof Jo Neill speaks with David Orren, CEO of GABA Labs, which has pioneered functional drinks with SENTIA Spirits. David recounts his initial co...

13 Maj 57min

149. Psilocybin for Cancer with Dr Lauren Macdonald

In this episode, we speak to Dr Lauren Macdonald, a psychiatrist, psychedelic therapist, and group retreat facilitator. She details her path to psychedelics, in particular her cancer diagnosis that le...

29 Apr 54min